Mostrando 5 resultados de: 5
Filtros aplicados
Publisher
International Journal of Stroke(2)
Cerebrovascular Diseases(1)
Current Problems in Cardiology(1)
The Lancet(1)
Clinical Perspective on Antihypertensive Drug Treatment in Adults With Grade 1 Hypertension and Low-to-Moderate Cardiovascular Risk: An International Expert Consultation
ReviewAbstract: Hypertension is a leading risk factor for disease burden globally. An unresolved question is whetherPalabras claves:Autores:Aguirre-Palacios F., Alcocer L., Barbosa E.C.D., Bertomeu-Martinez V., Bryce-Moncloa A., Burrell L.M., Coca A., Duenas-Herrera A., Kones R., Lanas F., Landrove O., Lavie C.J., Machado C.A., Morales Salinas A., Olsen M.H., Ordunez P., Orias M., Ortellado J., Parra-Carrillo J.Z., PATRICIO LOPEZ -JARAMILLO, Perez G., Pineiro D.J., Piskorz D.L., Prabhakaran D., Ramírez A.J., Redon J., Rodriguez Portelles A., Rodriguez-Leyva D., Sabio R., Sanchez R.A., Schutte A.E., Sebba-Barroso W.K., Sobrino J., Sundström J., Ventura H., Waisman G., Wang J.G., Weber M.A., Yano Y., Yusuf S., Zanchetti A.Fuentes:googlescopusA call to action and a lifecourse strategy to address the global burden of raised blood pressure on current and future generations: the Lancet Commission on hypertension
ReviewAbstract:Palabras claves:Autores:Angell S.Y., Asma S., Boutouyrie P., Burger D., Chirinos J.A., Damasceno A., Delles C., Gimenez-Roqueplo A.P., Hering D., Martinez F., Olsen M.H., PATRICIO LOPEZ -JARAMILLO, Perkovic V., Rietzschel E.R., Schillaci G., Schutte A.E., Scuteri A., Sharman J.E., Wachtell K., Wang J.G.Fuentes:googlescopusApplicability of ENCHANTED trial results to current acute ischemic stroke patients eligible for intravenous thrombolysis in England and Wales: Comparison with the Sentinel Stroke National Audit Programme registry
ArticleAbstract: Background: Randomized controlled trials provide high-level evidence, but the necessity to include sPalabras claves:acute ischemic stroke, Alteplase, Clinical trial, health outcomes, thrombolysisAutores:Arima H., Bath P.M.W., Bray B.D., Broderick J.P., Chalmers J., Durham A.C., Kim J.S., Lavados P.M., Lee T.H., Martins S.O., Nguyen T.H., Octavio Marques Pontes-Neto, Paley L., Pandian J.D., Parsons M.W., Ricci S., Robinson T.G., Rudd A.G., S Anderson C., Sharma V.K., Sprigg N., Wang J.G., Wang X., Woodward M.Fuentes:scopusLipid-lowering pretreatment and outcome following intravenous thrombolysis for acute ischaemic stroke: a post hoc analysis of the enhanced control of hypertension and thrombolysis stroke study trial
ArticleAbstract: Background: Debate exists as to whether statin pretreatment confers an increased risk of 90-day mortPalabras claves:Acute stroke outcome, Intracranial haemorrhage, Lipid-lowering therapy, OR, RISK FACTORS, statins, strokeAutores:Arima H., Bath P.M.W., Billot L., Broderick J.P., Chalmers J., Donnan G.A., Kim J.S., Lavados P.M., Lee T.H., Martins S.O., Minhas J.S., Octavio Marques Pontes-Neto, Olavarria V.V., Pandian J.D., Ricci S., Robinson T.G., S Anderson C., Sato S., Sharma V.K., Thang N.H., Wang J.G., Wang X., Woodward M.Fuentes:scopusRationale, design, and progress of the ENhanced Control of Hypertension ANd Thrombolysis strokE stuDy (ENCHANTED) trial: An international multicenter 2×2 quasi-factorial randomized controlled trial of low- vs. standard-dose rt-PA and early intensive vs. guideline-recommended blood pressure lowering in patients with acute ischaemic stroke eligible for thrombolysis treatment
ArticleAbstract: Rationale: Controversy exists over the optimal dose of intravenous (iv) recombinant tissue plasminogPalabras claves:Acute ischaemic stroke, Alteplase, Dose, Hypertension, Rt-PA, thrombolysisAutores:Arima H., Bath P.M.W., Broderick J.P., Chalmers J., Chen X., Demchuk A.M., Donnan G.A., Fuentes S., Huang Y., Kim J.S., Lavados P.M., Lee T.H., Levi C., Lindley R.I., Martins S.O., Nguyen T.H., Octavio Marques Pontes-Neto, Olavarria V.V., Pandian J.D., Parsons M.W., Ricci S., Robinson T.G., S Anderson C., Sharma V.K., Silva-Sieger F.A., Stapf C., Wang J.G., Woodward M.Fuentes:scopus